GP Diller, A Kempny, R Inuzuka, R Radke, SJ Wort… - Heart, 2014 - heart.bmj.com
Objectives To investigate survival in patients with Eisenmenger syndrome based on a systematic review of the literature and reanalysis of data. We specifically tested the …
Background—Eisenmenger syndrome is characterized by the development of pulmonary arterial hypertension with consequent intracardiac right-to-left shunt and hypoxemia in …
BACKGROUND: Bosentan, an oral endothelin ETA/ETB receptor antagonist, improves hemodynamics and exercise capacity in patients with Eisenmenger syndrome but longer …
EMC Chau, KYY Fan, WH Chow - International journal of cardiology, 2007 - Elsevier
BACKGROUND: To test the hypothesis that chronic sildenafil treatment has similar functional and hemodynamic effects in patients with severe pulmonary arterial hypertension …
ZN Zhang, X Jiang, R Zhang, XL Li, BX Wu, QH Zhao… - Heart, 2011 - heart.bmj.com
Background Although sildenafil has been shown to be safe and effective in idiopathic pulmonary arterial hypertension (PAH) and PAH related to connective tissue disease, its …
KS Cha, K Im Cho, JS Seo, JH Choi, YH Park… - The American journal of …, 2013 - Elsevier
There are limited data on the effect of iloprost therapy in patients with Eisenmenger syndrome (ES). The aim of our study was to evaluate the effect of inhaled iloprost therapy on …
E Oechslin, S Mebus, I Schulze-Neick… - Current cardiology …, 2010 - ingentaconnect.com
Eisenmenger syndrome is the most severe form of pulmonary arterial hypertension and arises on the basis of congenital heart disease with a systemic-to-pulmonary shunt. Due to …
Pulmonary hypertension (PH) refers to elevated pulmonary artery (PA) pressure (PAP), defined as mean PAP≥ 25 mm Hg. PH is not synonymous with pulmonary arterial …
AC Martin-Garcia, DRJ Arachchillage, A Kempny… - Heart, 2018 - heart.bmj.com
Objectives Although a significant proportion of patients with cyanotic congenital heart disease are thrombocytopaenic, its prevalence and clinical significance in adults with …